Literature DB >> 14500703

Clusterin expression in the early process of pancreas regeneration in the pancreatectomized rat.

Bon-Hong Min1, Byeong-Moo Kim, Seung-Hee Lee, Sang-Wook Kang, Moise Bendayan, In-Sun Park.   

Abstract

We have previously reported upregulation of clusterin at the time of islet cell regeneration after beta-cell injury. This led us to speculate that clusterin might be involved in the neogenic regeneration of the pancreas. Clusterin expression was examined throughout the process of pancreatic neogenesis in pancreatectomized rats. For in vitro analysis, duct cells were isolated from the rat pancreas and clusterin cDNA was transfected for its overexpression. Clusterin and its mRNA increased significantly in the early phase of regeneration, particularly at 1-3 days after pancreatectomy. Clusterin was transiently expressed in the differentiating acinar cells but faded afterwards. Interestingly, these clusterin cells were negative for PCNA (proliferating cell nuclear antigen), whereas most epithelial cells in ductules in the regenerating tissue showed extensive proliferative activity. Clusterin expression was also detected in some endocrine cells of the regenerating tissue. Transfection of clusterin cDNA into primary cultured duct cells resulted in a 2.5-fold increase in cell proliferation and induced transformation of non-differentiated duct cells into differentiated cells displaying cytokeratin immunoreactivity. Taken together, these results suggest that clusterin may play essential roles in the neogenic regeneration of pancreatic tissue by stimulating proliferation and differentiation of duct cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500703     DOI: 10.1177/002215540305101012

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  7 in total

1.  Clusterin synergizes with IL-2 for the expansion and IFN-γ production of natural killer cells.

Authors:  Chung Hee Sonn; Young-Bin Yu; Young-Joo Hong; Young-Jun Shim; Jeffrey A Bluestone; Bon-Hong Min; Kyung-Mi Lee
Journal:  J Leukoc Biol       Date:  2010-08-20       Impact factor: 4.962

2.  Clusterin induces differentiation of pancreatic duct cells into insulin-secreting cells.

Authors:  B M Kim; S Y Kim; S Lee; Y J Shin; B H Min; M Bendayan; I S Park
Journal:  Diabetologia       Date:  2006-01-13       Impact factor: 10.122

3.  Clusterin and Pycr1 alterations associate with strain and model differences in susceptibility to experimental pancreatitis.

Authors:  Sapna Iyer; Min-Jung Park; David Moons; Raymond Kwan; Jian Liao; Li Liu; M Bishr Omary
Journal:  Biochem Biophys Res Commun       Date:  2016-12-07       Impact factor: 3.575

4.  Inhibition of Mist1 homodimer formation induces pancreatic acinar-to-ductal metaplasia.

Authors:  Liqin Zhu; Thai Tran; J Michael Rukstalis; Peichuan Sun; Barbara Damsz; Stephen F Konieczny
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

Review 5.  Clusterin: a key player in cancer chemoresistance and its inhibition.

Authors:  Tomas Koltai
Journal:  Onco Targets Ther       Date:  2014-03-20       Impact factor: 4.147

6.  Clusterin is highly expressed in tubular complexes during spontaneous pancreatitis of spontaneous hypertensive rats.

Authors:  Jun Won Park; Ki Taek Nam; Jae Hoon Shin; Il Yong Kim; Kyung Mi Choi; Kyung-Jin Roh; Seung Hyun Oh; Young-Min Yun; Jun-Gyo Suh; Yang-Seok Oh; Yeo Sung Yoon; Je Kyung Seong
Journal:  J Vet Med Sci       Date:  2018-08-16       Impact factor: 1.267

7.  Clinical significance of clusterin expression in pancreatic adenocarcinoma.

Authors:  Junshuo Jin; Joon-Mee Kim; Yoon-Seok Hur; Won Pyo Cho; Keon-Young Lee; Seung-Ik Ahn; Kee Chun Hong; In-Sun Park
Journal:  World J Surg Oncol       Date:  2012-07-16       Impact factor: 2.754

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.